A follow-up visit is a return appointment to review what has happened since an earlier assessment and clarify what happens next. For a GLP-1 treatment discussion, bring the information the clinician requested, your questions and any difficulty understanding or carrying out the plan. A refill transaction and a clinical reassessment are different questions; this guide helps you prepare for the conversation without deciding its outcome.
NIDDK advises discussing how well a weight-management medicine works and its side effects with a health professional. The appropriate duration and ongoing plan depend on that assessment. This briefing does not set a universal visit schedule or a numerical threshold for continuing treatment.
NIDDK identifies benefits, possible adverse effects, other medicines and cost as discussion factors. Its page was reviewed in June 2024 and retrieved again November 13, 2026. That general guidance does not establish your visit timetable, a personal stopping rule or a complete current list of medicines. [November 13 source]
A one-page record to prepare
Use the headings below as a conversation aid. They are editorial prompts, not a required medical form or an instruction to collect measurements that your clinician has not requested. Write what you observed and what you want clarified; leave interpretation to the professional reviewing the record.
| Heading | Your record | Question to bring |
|---|---|---|
| Since the last review | What you noticed, when it happened and what you were doing. | Which of these observations matter to the decision today? |
| Current plan | The instructions you received and the point you do not understand. | Can we confirm the instructions that apply to me? |
| Practical difficulty | A cost, access or communication problem and the step still unresolved. | Who can address this, and what should I do while awaiting an answer? |
| After the discussion | The clinician's conclusion, any written instructions and the next contact. | Who owns the next step and when should I expect to hear from them? |
For example, “I received two different instructions and do not know which one applies” is a clearer question than silently choosing one. Keep the wording available for the professional to examine. Likewise, write “I have not received a medication-cost answer” rather than assuming that a membership payment resolved it. These examples show how to make an uncertainty visible; they do not interpret a prescription or tell you to change treatment.
Before the appointment ends, read back the part you are still unsure about. Ask where the agreed instructions will be recorded and how to request clarification later. The useful result is a named next step and a way to resolve uncertainty, not a conclusion borrowed from another person's experience.
Describe what changed since the last review
Bring the observations the clinician asked you to track, along with new symptoms or questions. Explain timing and context without deciding the cause in advance. If something is urgent, use the service's escalation instructions rather than saving it for a routine appointment.
Include changes in other medicines, supplements or care. FDA's medication-list guidance is useful here: a current record helps the clinician see the wider treatment picture. An old list can hide a change that another professional made after the original assessment.
Make practical difficulties visible
Tell the clinician if cost, access, packaging or scheduling has affected your ability to follow the plan. A treatment that is difficult to obtain or understand needs that problem addressed. Do not improvise a different schedule and present it as though nothing changed.
If a label or instruction is unclear, bring the actual wording. The clinician and dispensing pharmacist can determine what clarification is needed. An online article cannot reconstruct your prescription from a general description of the product.
Ask how the assessment changes the next step
The National Institute on Aging encourages questions about treatment and what to expect. Ask what the clinician concludes from the information you provided and whether any additional evaluation is needed. If the plan changes, request the new instructions in an understandable form.
Also ask who will communicate with the pharmacy or another clinician. A recommendation in a visit note does not necessarily mean every organization has received it. Keep the responsible contact and expected timing with the plan.
Leave with a review point
Write down when follow-up is expected and which concerns should prompt earlier contact. The aim is a usable pathway back to care, not a fixed rule borrowed from someone else's treatment experience.
Our profiles of Form Health and PlushCare describe different advertised care arrangements. They do not determine how frequently you personally need assessment. Pair this briefing with the testing guide when a follow-up includes a new laboratory or other diagnostic question.
Source notes
Supplemental checks are dated November 13, 2026. Earlier records retain their original check dates; a new page edit does not refresh every source. Provider pages document advertised terms. Study summaries identify the scope of our review.
- Prescription Medications to Treat Overweight & Obesity - NIDDKPrimary health resource; checked October 5, 2026
- It can be a lifesaving tool, especially during an emergencyPrimary health resource; checked October 5, 2026
- What Should I Ask My Doctor During a Checkup?Primary health resource; checked October 5, 2026
- NIDDK — prescription weight-management medicines, June 2024 reviewGeneral patient education; review date June 2024 · Checked November 13, 2026